New advances in the treatment of intermediate and advanced hepatocellular carcinoma

J Zhonghao, Y Fan - Frontiers in Oncology, 2024 - pmc.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, affecting millions
of people worldwide. Due to the complexity and variability of the disease, there are major …

Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors

Q Yu, Y Wang, E Ungchusri, A Pillai, C Liao… - Journal of Vascular and …, 2024 - Elsevier
Purpose To assess the safety and effectiveness of using modified radiation lobectomy (mRL)
to treat primary hepatic tumors located in the right hepatic lobe (Segments V–VIII) and to …

Uso da Reciclagem de Vidros para Fins Médicos: Produção de Microesferas de Vidro Dopadas com Holmio-166 para Radioembolização Hepatocelular

SRR Reis - 2024 - bdtd.uerj.br
RESUMO REIS, Sara Rhaissa Rezende dos. Uso da Reciclagem de Vidros para Fins
Médicos: Produção de Microesferas de Vidro Dopadas com Holmio-166 para …

Hepatic Arterial Infusion Chemotherapy for Unresectable HCC: Ready for Primetime?

Q Yu, O Ahmed - Academic Radiology, 2024 - academicradiology.org
I n the context of intra-arterial based locoregional therapy for unresectable hepatocellular
carcinoma (HCC), transarterial chemoembolization (TACE) has stood as the standard of …